Cargando…
Necessity of Temporal Artery Biopsy for Giant Cell Arteritis: A Systematic Review
Temporal artery biopsy (TAB) is currently the gold standard procedure to diagnose giant cell arteritis. Despite low sensitivity, TAB is routinely performed even if a clinical diagnosis has already been made. The objective of this study was to determine the usefulness of TAB for giant cell arteritis...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126522/ https://www.ncbi.nlm.nih.gov/pubmed/35620490 http://dx.doi.org/10.1097/GOX.0000000000004185 |
_version_ | 1784712148358791168 |
---|---|
author | Ponich, Brett Hartley, Rebecca Lafreniere, Ann-Sophie Temple-Oberle, Claire F. |
author_facet | Ponich, Brett Hartley, Rebecca Lafreniere, Ann-Sophie Temple-Oberle, Claire F. |
author_sort | Ponich, Brett |
collection | PubMed |
description | Temporal artery biopsy (TAB) is currently the gold standard procedure to diagnose giant cell arteritis. Despite low sensitivity, TAB is routinely performed even if a clinical diagnosis has already been made. The objective of this study was to determine the usefulness of TAB for giant cell arteritis management. METHODS: We performed a systematic review to identify studies that compared steroid treatment between TAB+ and TAB− patients. EMBASE, MEDLINE, and the Cochrane Central Register of Controlled Trials were searched from inception until April 4, 2020. Titles, abstracts, and full texts were reviewed by two independent reviewers and conflicts resolved by consensus. Studies reporting TAB result and steroid treatment were included. Information pertaining to steroid treatment was compared between TAB+ and TAB− groups. Steroid duration was compared by grouping patients in a less than 6 month group, a 6–24 month group, and a more than 24 month group. RESULTS: An estimated 5288 abstracts were screened and 13 studies involving 1355 patients were included. Rate of prebiopsy steroid treatment was higher in TAB+ patients compared with TAB− patients [93% versus 63% (P < 0.001)]. The TAB+ group was more likely to be started on steroids prebiopsy [28% versus 8% (P < 0.001)]. TAB+ and TAB− patients had similar steroid duration for all groups [<6-month group 17% versus 19% (P-0.596), the 6-24-month group 16% versus 19% (P-0.596), and the >24-month group 66% versus 63% (P-0.642)]. CONCLUSION: TAB results have minimal impact on treatment, and the utility should be reconsidered when a clinical diagnosis of giant cell arteritis is possible. |
format | Online Article Text |
id | pubmed-9126522 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-91265222022-05-25 Necessity of Temporal Artery Biopsy for Giant Cell Arteritis: A Systematic Review Ponich, Brett Hartley, Rebecca Lafreniere, Ann-Sophie Temple-Oberle, Claire F. Plast Reconstr Surg Glob Open Global Health Temporal artery biopsy (TAB) is currently the gold standard procedure to diagnose giant cell arteritis. Despite low sensitivity, TAB is routinely performed even if a clinical diagnosis has already been made. The objective of this study was to determine the usefulness of TAB for giant cell arteritis management. METHODS: We performed a systematic review to identify studies that compared steroid treatment between TAB+ and TAB− patients. EMBASE, MEDLINE, and the Cochrane Central Register of Controlled Trials were searched from inception until April 4, 2020. Titles, abstracts, and full texts were reviewed by two independent reviewers and conflicts resolved by consensus. Studies reporting TAB result and steroid treatment were included. Information pertaining to steroid treatment was compared between TAB+ and TAB− groups. Steroid duration was compared by grouping patients in a less than 6 month group, a 6–24 month group, and a more than 24 month group. RESULTS: An estimated 5288 abstracts were screened and 13 studies involving 1355 patients were included. Rate of prebiopsy steroid treatment was higher in TAB+ patients compared with TAB− patients [93% versus 63% (P < 0.001)]. The TAB+ group was more likely to be started on steroids prebiopsy [28% versus 8% (P < 0.001)]. TAB+ and TAB− patients had similar steroid duration for all groups [<6-month group 17% versus 19% (P-0.596), the 6-24-month group 16% versus 19% (P-0.596), and the >24-month group 66% versus 63% (P-0.642)]. CONCLUSION: TAB results have minimal impact on treatment, and the utility should be reconsidered when a clinical diagnosis of giant cell arteritis is possible. Lippincott Williams & Wilkins 2022-05-20 /pmc/articles/PMC9126522/ /pubmed/35620490 http://dx.doi.org/10.1097/GOX.0000000000004185 Text en Copyright © 2022 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Global Health Ponich, Brett Hartley, Rebecca Lafreniere, Ann-Sophie Temple-Oberle, Claire F. Necessity of Temporal Artery Biopsy for Giant Cell Arteritis: A Systematic Review |
title | Necessity of Temporal Artery Biopsy for Giant Cell Arteritis: A Systematic Review |
title_full | Necessity of Temporal Artery Biopsy for Giant Cell Arteritis: A Systematic Review |
title_fullStr | Necessity of Temporal Artery Biopsy for Giant Cell Arteritis: A Systematic Review |
title_full_unstemmed | Necessity of Temporal Artery Biopsy for Giant Cell Arteritis: A Systematic Review |
title_short | Necessity of Temporal Artery Biopsy for Giant Cell Arteritis: A Systematic Review |
title_sort | necessity of temporal artery biopsy for giant cell arteritis: a systematic review |
topic | Global Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126522/ https://www.ncbi.nlm.nih.gov/pubmed/35620490 http://dx.doi.org/10.1097/GOX.0000000000004185 |
work_keys_str_mv | AT ponichbrett necessityoftemporalarterybiopsyforgiantcellarteritisasystematicreview AT hartleyrebecca necessityoftemporalarterybiopsyforgiantcellarteritisasystematicreview AT lafreniereannsophie necessityoftemporalarterybiopsyforgiantcellarteritisasystematicreview AT templeoberleclairef necessityoftemporalarterybiopsyforgiantcellarteritisasystematicreview |